Work

Effect of treatment with benralizumab or mepolizumab on the serum proteome in eosinophilic granulomatosis with polyangiitis

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa828

Authors: Eva Rodriguez-Suarez, Mathias Cardner, Michael E. Wechsler, Peter A. Merkel, Benjamin Terrier, David R. W. Jayne, Florence Roufosse, Nancy Agmon-Levin, Lena Börjesson Sjö, Sofia Necander, Maria Jison, Daniel Muthas, Christopher Mccrae

Institutions: AstraZeneca (United Kingdom), AstraZeneca (Sweden), National Jewish Health, University of Pennsylvania, Université Paris Cité, Hôpital Cochin, University of Cambridge, Université Libre de Bruxelles, Erasmus Hospital, Sheba Medical Center, AstraZeneca (United States)

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404101620

Cites:

Cited by: 1

Related to: 10